SEC Tracker
Get the app

Pacira BioSciences PCRX

Pacira BioSciences (PCRX) announces acquisition by Viatris Inc.

SC TO-C filing

Form
Schedule TO-C
Filed
Importance
Routine
  1. Viatris Inc. plans to acquire Pacira BioSciences, Inc.
  2. The acquisition includes all outstanding shares of Pacira's common stock.
  3. The tender offer is expected to be accretive to Viatris's portfolio.
  4. The transaction is subject to regulatory approvals and shareholder approvals.

Written from the Schedule TO-C on EDGAR. AI can make mistakes. Check the filing.

Open in the appGet the appView on EDGAR

Get an email when Pacira BioSciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  2. uniQure QURE public float $765M, Jun 30, 2025
  3. Cogent Biosciences COGT public float $773M, Jun 30, 2025
  4. Immunome IMNM public float $729M, Jun 30, 2025
  5. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025

Data on this page was fetched . The filing on SEC.gov is the record.